Long Focus Capital Management, LLC Cellectis S.A. Transaction History
Long Focus Capital Management, LLC
- $2.73 Billion
- Q3 2024
A detailed history of Long Focus Capital Management, LLC transactions in Cellectis S.A. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 4,617,293 shares of CLLS stock, worth $7.3 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
4,617,293
Previous 4,617,293
-0.0%
Holding current value
$7.3 Million
Previous $8.63 Million
13.37%
% of portfolio
0.36%
Previous 0.35%
Shares
7 transactions
Others Institutions Holding CLLS
# of Institutions
30Shares Held
10.8MCall Options Held
5.9KPut Options Held
1.4K-
Capital International Investors Los Angeles, CA1.85MShares$2.92 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.44MShares$2.27 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$2.27 Million0.0% of portfolio
-
Baillie Gifford & CO694KShares$1.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C3227KShares$358,4620.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $71.9M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...